61786-0575 Ondansetron

Product NDC:

61786-0575

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 4.0

Unit: mg/1

Packages:

Code: 61786-0575-02

Description: 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (61786-575-02)

Effective Date: April 8, 2016

Discontinued: Jan. 23, 2017

Code: 61786-0575-08

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 VIAL (61786-575-08)

Effective Date: April 5, 2016

Discontinued: Nov. 8, 2016

Code: 61786-0575-10

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 VIAL (61786-575-10)

Effective Date: Feb. 2, 2016

Discontinued: Feb. 23, 2017

Code: 61786-0575-17

Description: 4 TABLET, ORALLY DISINTEGRATING in 1 VIAL (61786-575-17)

Effective Date: Feb. 25, 2016

Discontinued: Nov. 11, 2016

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox